KIM LLC’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,666
Closed -$4K 655
2022
Q4
$4K Hold
16,666
﹤0.01% 551
2022
Q3
$1K Hold
16,666
﹤0.01% 824
2022
Q2
$2K Buy
+16,666
New +$2.82K ﹤0.01% 847

KIM LLC's EBACW Position: Q1 2023 in Review

KIM LLC sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 16,666 shares — an estimated $4K sold.

KIM LLC first reported a position in EBACW in Q2 2022 and held it in 3 quarters. The position peaked at $4K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • KIM LLC reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • KIM LLC sold 16,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $4K.
  • KIM LLC first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2022 and held it in 3 quarters.
  • KIM LLC's European Biotech Acquisition Corp. Warrant position peaked at $4K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on KIM LLC's 13F filing for Q1 2023, filed 11 May 2023.